SCHEMBL5906847

SCHEMBL5906847

O=C(O)[C@H](Cc1ccccc1)Nc1cc(-c2ccc(/C=C\c3ccccc3)cc2)ncn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 6/20 0.44
ITGA4 P13612 6/20 0.44
PPARG P37231 4/20 0.44
ALDH1A1 P00352 3/20 0.44
CYP1A2 P05177 3/20 0.44
HSD17B10 Q99714 3/20 0.44
CYP2D6 P10635 2/20 0.44
CLK4 Q9HAZ1 2/20 0.44
PPARA Q07869 1/20 0.42
NOS2 P35228 1/20 0.42
CYP3A4 P08684 2/20 0.41
ADORA2A P29274 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5906763 1.00 ITGB1 (0.44) ITGB1ITGA4PPARGALDH1A1CYP1A2
SCHEMBL5906773 1.00 ITGB1 (0.44) ITGB1ITGA4PPARGALDH1A1CYP1A2
SCHEMBL5906766 1.00 ITGB1 (0.44) ITGB1ITGA4PPARGALDH1A1CYP1A2
SCHEMBL5906842 1.00 ITGB1 (0.44) ITGB1ITGA4PPARGALDH1A1CYP1A2
SCHEMBL5906770 1.00 ITGB1 (0.44) ITGB1ITGA4PPARGALDH1A1CYP1A2
SCHEMBL5906633 0.89 NOS2 (0.47) ITGB1ITGA4ALDH1A1CYP1A2HSD17B10
SCHEMBL5906715 0.89 NOS2 (0.47) ITGB1ITGA4ALDH1A1CYP1A2HSD17B10
SCHEMBL5906718 0.89 NOS2 (0.47) ITGB1ITGA4ALDH1A1CYP1A2HSD17B10
SCHEMBL5906632 0.89 NOS2 (0.47) ITGB1ITGA4ALDH1A1CYP1A2HSD17B10
SCHEMBL5906630 0.89 NOS2 (0.47) ITGB1ITGA4ALDH1A1CYP1A2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060089371-A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist BAYER HEALTHCARE AG (DE) 2006-04-27 US disclosed
CN-1735598-A Phenyl or heteroaryl amino alkane derivatives as IP receptor antagonist BAYER HEALTHCARE AG (DE) 2006-02-15 CN disclosed
EP-1575919-A1 PHENYL OR HETEROARYL AMINO ALKANE DERIVATIVES AS IP RECEPTOR ANTAGONIST Bayer HealthCare AG (DE) 2005-09-21 EP disclosed
WO-2004043926-A1 PHENYL OR HETEROARYL AMINO ALKANE DERIVATIVES AS IP RECEPTOR ANTAGONIST BAYER HEALTHCARE AG (DE) 2004-05-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089371-A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist BPHL, HRH4, HRH2 ITGB1 1017/4885ITGA4 347/4885PPARG 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.